Back

Impact of visceral adipose tissue on mortality in patients undergoing transcatheter aortic valve implantation

26 August 2023 (15:15 - 15:50)
Organised by: Logo
Congress Presentation Part of: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Alberto Somaschini

San Paolo Hospital, Savona (Italy)

6 More presentations in this session

Presentation thumbnail
High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes
Doctor J. Strange (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?
Doctor V. Panoulas (Harefield, Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR
Doctor P. Jimenez-Quevedo (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation
Doctor D. Hesselbarth (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry
Doctor K. Nilsson (Uppsala, SE)
Abstract Slides Video

Access the full session

Session thumbnail
TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Does obesity impact outcomes in TAVI? A systematic review and meta-analysis
thumbnail
Congress Presentation
Epicardial adipose tissue volumes for long-term risk stratification in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
thumbnail
Congress Presentation
Improving risk stratification in TAVI: the role of epicardial fat, visceral fat and adiponectin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources